Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
24 October 2014
Header
Header image
From our blog

From our blog

Nagoya Protocol Enters into Force: Challenges ahead
20 October 2014 by

On 12th October, the Nagoya Protocol entered into force, for its 51 Parties, 4 years after its adoption by the Conference of the Parties to the Convention on Biological Diversity (CBD). It provides a framework which, if it is implemented in a practical manner, will promote the access and benefit sharing objective of the CBD.

Read more

From our blog

Is Europe still counting on the confidence fairy?
20 October 2014 by

Last week we had our annual conference in Brussels. This year’s keynote speaker was MEP and former Belgian Prime Minister Guy Verhofstadt. He gave an impressive and passionate speech about what Europe needs to do to finally get itself out of the economic crisis. Much of what he said made a lot of sense, but on a couple of critical issues I think he is barking up the wrong tree. Unfortunately, what was missing in his analysis is also missing in that of a lot of European economic policymakers, and that’s a worry.

Read more

From our blog

Finding Solutions Together: EFPIA and Health Care Without Harm Meet to Discuss Pharmaceuticals in the Environment
21 October 2014 by

On 24 October, EFPIA and Health Care Without Harm (HCWH) will host a joint workshop on PiE – Pharmaceuticals in the Environment. Even though the workshop on the 24th of October is invitation-only, the organisers are happy to invite everyone to participate through twitter.

Read more

From our blog

Animal testing? Yes, but…
21 October 2014 by

The Swiss are somewhat sceptical about animal testing for research purposes. This unsurprising stance was most recently shown in a representative survey of 1000 Swiss voters conducted by gfs.bern on behalf of Interpharma.

Read more

Videos

Video

Re-test or Expiry Date Labelling in Clinical Trials

The Regulation allows Annex VI to be updated. EFPIA is calling on the European Commission and the Parliament, as well as the Member States, to raise this issue and request that the labelling requirements in Annex VI are changed back to the original wording of the Commission’s proposal, before the Regulation is implemented.   

View video

Events calendar

Events Calendar

FT Global Pharmaceutical and Biotechnology Conference - Predictions 2020: The Future of the Industry
From 17/11/2014 to 18/11/2014 (London, UK )

The future is arriving fast for the life science industry. Convergence is happening along the entirety of the industry value chain, blurring the boundaries between pharma, biotech, [...] Read more

Events Calendar

EV Healthcheck Forum 2015
On 04/11/2014 (Brussels, Belgium )

This comes at a moment where health systems around the world are at a crossroads. Ageing population, increasing cost of technologies, unhealthy lifestyles, rising patient expectations… [...] Read more

What we are reading

What we are reading

European Union to boost Ebola research with €24.4 million
23 October 2014

The European Commission has announced €24.4 million from the EU budget for urgently needed Ebola research. The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. The money from Horizon 2020, the EU research and innovation programme, will be provided via a fast-track procedure in order to start work as soon as possible.The Commission is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola and other haemorrhagic diseases within the Innovative Medicines Initiative.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail